Sage's CEO reflects on progress treating postpartum depression - STAT

Sage's CEO reflects on progress treating postpartum depression - STAT

STAT Plus: Sage’s CEO reflects on progress treating postpartum depression and what Biogen’s big Alzheimer’s failure means

By ALISSA AMBROSE AND ADAM FEUERSTEIN AND MATTHEW HERPER

JESSICA RINALDI/THE BOSTON GLOBE

Sage Therapeutics CEO Jeff Jonas chats about his company's success with a postpartum depression drug and Biogen's failure in Alzheimer's.

READ MORE